These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20699352)

  • 1. Dexamphetamine-induced reduction of P3a and P3b in healthy participants.
    Albrecht MA; Martin-Iverson MT; Price G; Lee J; Iyyalol R
    J Psychopharmacol; 2011 Dec; 25(12):1623-31. PubMed ID: 20699352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamphetamine reduces auditory P3 delta power and phase-locking while increasing gamma power.
    Albrecht MA; Price G; Lee J; Iyyalol R; Martin-Iverson MT
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):734-46. PubMed ID: 22440975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Event-related potentials in adolescents with schizophrenia and their siblings: a comparison with attention-deficit/hyperactivity disorder.
    Groom MJ; Bates AT; Jackson GM; Calton TG; Liddle PF; Hollis C
    Biol Psychiatry; 2008 Apr; 63(8):784-92. PubMed ID: 17977520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired P3 generation reflects high-level and progressive neurocognitive dysfunction in schizophrenia.
    van der Stelt O; Frye J; Lieberman JA; Belger A
    Arch Gen Psychiatry; 2004 Mar; 61(3):237-48. PubMed ID: 14993111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
    Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
    Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: a single-dose study.
    Lee H; Wang GY; Curley LE; Sollers JJ; Kydd RR; Kirk IJ; Russell BR
    Psychopharmacology (Berl); 2016 Mar; 233(5):863-71. PubMed ID: 26630992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cortical generators of P3a and P3b: a LORETA study.
    Volpe U; Mucci A; Bucci P; Merlotti E; Galderisi S; Maj M
    Brain Res Bull; 2007 Jul; 73(4-6):220-30. PubMed ID: 17562387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auditory and visual P300 reflecting cognitive improvement in patients with schizophrenia with quetiapine: a pilot study.
    Park EJ; Han SI; Jeon YW
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):674-80. PubMed ID: 20304022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline-dependent modulating effects of nicotine on voluntary and involuntary attention measured with brain event-related P3 potentials.
    Knott V; Choueiry J; Dort H; Smith D; Impey D; de la Salle S; Philippe T
    Pharmacol Biochem Behav; 2014 Jul; 122():107-17. PubMed ID: 24690514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Event-related wave activity in the EEG provides new marker of ADHD.
    Alexander DM; Hermens DF; Keage HA; Clark CR; Williams LM; Kohn MR; Clarke SD; Lamb C; Gordon E
    Clin Neurophysiol; 2008 Jan; 119(1):163-79. PubMed ID: 18054279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamphetamine normalises electrophysiological activity in attention deficit-hyperactivity disorder during the Stroop task.
    Horrobin SL; McNair NA; Kirk IJ; Waldie KE
    Neurocase; 2007 Oct; 13(5):301-10. PubMed ID: 18781428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature disinhibition of P3 generation in schizophrenia.
    Shelley AM; Grochowski S; Lieberman JA; Javitt DC
    Biol Psychiatry; 1996 Apr; 39(8):714-9. PubMed ID: 8731459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamphetamine selectively increases 40 Hz auditory steady state response power to target and nontarget stimuli in healthy humans.
    Albrecht MA; Price G; Lee J; Iyyalol R; Martin-Iverson MT
    J Psychiatry Neurosci; 2013 Jan; 38(1):24-32. PubMed ID: 22894820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P3 and delta band responses in visual oddball paradigm in schizophrenia.
    Ergen M; Marbach S; Brand A; Başar-Eroğlu C; Demiralp T
    Neurosci Lett; 2008 Aug; 440(3):304-8. PubMed ID: 18571323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in PASAT performance correlates with change in P3 ERP amplitude over a 12-month period in multiple sclerosis patients.
    Kiiski H; Reilly RB; Lonergan R; Kelly S; O'Brien M; Kinsella K; Bramham J; Burke T; O'Donnchadha S; Nolan H; Hutchinson M; Tubridy N; Whelan R
    J Neurol Sci; 2011 Jun; 305(1-2):45-52. PubMed ID: 21457995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7 mg nicotine patch fails to enhance P300 neural indices of cognitive control among nonsmokers.
    Evans DE; Jentink KG; Sutton SK; Van Rensburg KJ; Drobes DJ
    Pharmacol Biochem Behav; 2014 Nov; 126():77-82. PubMed ID: 25218552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auditory event-related potential abnormalities in bipolar disorder and schizophrenia.
    O'Donnell BF; Vohs JL; Hetrick WP; Carroll CA; Shekhar A
    Int J Psychophysiol; 2004 Jun; 53(1):45-55. PubMed ID: 15172135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P300 deficits in adults with attention deficit hyperactivity disorder: a meta-analysis.
    Szuromi B; Czobor P; Komlósi S; Bitter I
    Psychol Med; 2011 Jul; 41(7):1529-38. PubMed ID: 20961477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention.
    Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS
    J Psychopharmacol; 2006 Nov; 20(6):789-98. PubMed ID: 16478755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating cortical patterns of cognitive dysfunction in schizophrenia and posttraumatic stress disorder.
    Galletly CA; McFarlane AC; Clark R
    Psychiatry Res; 2008 May; 159(1-2):196-206. PubMed ID: 18423610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.